AOTI, Inc. Reports Strong H1 2024 Financial Growth

AOTI, Inc. (GB:AOTI) has released an update.

AOTI, Inc., a medical technology company specializing in wound care and amputation prevention, reports strong first-half 2024 financial results with a 26.4% increase in revenue and a significant improvement in EBITDA. The company has expanded its business segments, secured a Veterans Administration contract extension, and completed a successful IPO, raising £19.5 million. AOTI’s innovative therapies have shown to drastically reduce hospitalizations and amputations, with a growing patient base treated in the US.

For further insights into GB:AOTI stock, check out TipRanks’ Stock Analysis page.